Guoliang Jiang

BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · Journal of Clinical Oncology · 2015 · 381 citations · Full text

Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance

Shi‐Xiong Liang, Xiaodong Zhu, Zhiyong Xu et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 278 citations

Hepatic Disorders, Hepatology, Radiation Therapy +11

Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation

Jian Zheng, Xudong Huang, Wen Tan et al. · Nature Genetics · 2016 · 271 citations

Ptpn11 Degradation, Pancreatic Cancer, Pathology +7

Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations

Chen Wu, Xiaoping Miao, Liming Huang et al. · Nature Genetics · 2011 · 192 citations

Genome-wide Association Study, Epidemiology, Chinese Populations +9

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus

Zhao‐Chong Zeng, Jia Fan, Zhao–You Tang et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 181 citations

Hepatology, Radiation Therapy, Medicine +10